---
figid: PMC7175546__13045_2020_874_Fig3_HTML
figtitle: PARP inhibitors in cancer therapy
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Vicia faba var. minor
organisms_ner:
- Homo sapiens
pmcid: PMC7175546
filename: 13045_2020_874_Fig3_HTML.jpg
figlink: pmc/articles/PMC7175546/figure/Fig3/
number: F3
caption: The role of PARP inhibitors in cancer therapy. PARP inhibitors are effective
  in HR-deficient cancer cells by the mechanism of synthetic lethality (left panel)
  and by PARP trapping (right panel). Other mechanisms of PARPi action are described
  in the text
papertitle: Participation of the ATR/CHK1 pathway in replicative stress targeted therapy
  of high-grade ovarian cancer.
reftext: Patrycja Gralewska, et al. J Hematol Oncol. 2020;13:39.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9696878
figid_alias: PMC7175546__F3
figtype: Figure
redirect_from: /figures/PMC7175546__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7175546__13045_2020_874_Fig3_HTML.html
  '@type': Dataset
  description: The role of PARP inhibitors in cancer therapy. PARP inhibitors are
    effective in HR-deficient cancer cells by the mechanism of synthetic lethality
    (left panel) and by PARP trapping (right panel). Other mechanisms of PARPi action
    are described in the text
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHEK1
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - MAP6
---
